Moreover , treatment with selective serotonin reuptake inhibitor compared to placebo was associated with a significant reduction in estimated mean depressive symptoms measured by SCL-@ ( P = @ ) and BDI ( P = @ ) , but not with MADRS ( P = @ ) .